—

Dr. Reddy’s Laboratories Ltd ADR (RDY) — the peer cohort

As of 2026-11-03 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Dr. Reddy’s Laboratories Ltd ADR ranks 7 of 7 in its cohort on the Closelooknet composite (49/100) — the cohort is led by Laboratorios Farmaceuticos ROVI at 63/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
RDY Dr. Reddy’s Laboratories Ltd ADR 49 66 41 57 info 7.8%
ROVI.MC Laboratorios Farmaceuticos ROVI 63 48 77 48 info 25.8%
LNTH Lantheus Holdings Inc 60 73 73 54 ok 9.9%
GALDY GALDERMA GROUP AG 57 70 59 22 ok 2.3%
KNSA Kiniksa Pharmaceuticals Ltd 56 92 58 18 ok 5.3%
ALM.MC Almirall S.A. 55 42 46 66 info 21%
IRWD Ironwood Pharmaceuticals Inc 55 25 77 84 warn 39.4%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-03

Quick answers

Who are Dr. Reddy’s Laboratories Ltd ADR's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Lantheus Holdings Inc (LNTH), GALDERMA GROUP AG (GALDY), Kiniksa Pharmaceuticals Ltd (KNSA), Almirall S.A. (ALM.MC), Ironwood Pharmaceuticals Inc (IRWD), as of 2026-11-03.

How does RDY score against its peers?

Dr. Reddy’s Laboratories Ltd ADR's composite reads 49/100, ranking 7 of 7 in its cohort as of 2026-11-03; the cohort's highest composite is Laboratorios Farmaceuticos ROVI at 63/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.